Cancer drug hope raises Genmab's spirits after legal defeat
Biotech firm Genmab and partner Abbvie have delivered promising topline data from their shared drug hope epcoritamab, a bone marrow cancer treatment. An important validation for Genmab, assesses an analyst, as the company recently lost an important legal battle.
by BENJAMIN WERNER CHRISTENSEN, translated by daniel pedersen
The show must go on, as the saying goes, which is also true for the biotech sector.
Although the wind was knocked out of Genmab shortly before Easter when the company’s partner Janssen won a legal case against the firm, things are brightening up.
Bavarian has been the center of attention in recent days due to its monkeypox vaccine, and the company has now secured a vaccine contract with another undisclosed country. Consequently, Bavarian has raised its expectations for the full year.